Discovery of Potent, Isoform-Selective Inhibitors of Histone Deacetylase Containing Chiral Heterocyclic Capping Groups and a N-(2-Aminophenyl)benzamide Binding Unit

详细信息    查看全文

• 作者：Charles M. Marson ; Christopher J. Matthews ; Elena Yiannaki ; Stephen J. Atkinson ; Peter E. Soden ; Lena Shukla ; Nermina Lamadema ; N. Shaun B. Thomas
• 刊名：Journal of Medicinal Chemistry
• 出版年：2013
• 出版时间：August 8, 2013
• 年：2013
• 卷：56
• 期：15
• 页码：6156-6174
• 全文大小：855K
• 年卷期：v.56,no.15(August 8, 2013)
• ISSN：1520-4804

文摘

The synthesis of a novel series of potent chiral inhibitors of histone deacetylase (HDAC) is described that contain a heterocyclic capping group and a N-(2-aminophenyl)benzamide unit that binds in the active site. In vitro assays for the inhibition of HDAC1, HDAC2, HDAC3-NCoR1, and HDAC8 by the N-(2-aminophenyl)benzamide <b>24ab> gave respective ICb>50b> values of 930, 85, 12, and 4100 nM, exhibiting class I selectivity and potent inhibition of HDAC3-NCoR1. Both imidazolinone and thiazoline rings are shown to be effective replacements for the pyrimidine ring present in many other 2-(aminophenyl)benzamides previously reported, an example of each ring system at 1 渭M causing an increase in histone H3K9 acetylation in the human cell lines Jurkat and HeLa and an increase in cell death consistent with induction of apoptosis. Inhibition of the growth of MCF-7, A549, DU145, and HCT116 cell lines by <b>24ab> was observed, with respective ICb>50b> values of 5.4, 5.8, 6.4, and 2.2 mM.